|
Market Closed -
Nasdaq
16:00:00 2024-11-19 EST
|
5-day change | 1st Jan Change | ||
| 4.840 USD | +3.20% |
|
-.--% | - |
| 24-11-20 | Exscientia plc(NasdaqGS:EXAI) dropped from S&P Global BMI Index | CI |
| 24-11-20 | Recursion Pharmaceuticals, Exscientia Complete Business Combination | MT |
Company Valuation: Exscientia plc
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Market Cap 1 | 1,757 | 543.6 | 628.7 |
| Change | - | -69.06% | 15.67% |
| Enterprise Value (EV) 1 | 1,200 | 51.65 | 284.6 |
| Change | - | -95.69% | 451% |
| P/E | -14.8x | -4.55x | -4.28x |
| PBR | 3.11x | 1.14x | 1.78x |
| PEG | -0x | 3.03x | -0.2x |
| Capitalization / Revenue | 64.2x | 20x | 31.3x |
| EV / Revenue | 43.9x | 1.9x | 14.2x |
| EV / EBITDA | -23.4x | -0.32x | -1.75x |
| EV / EBIT | -22x | -0.31x | -1.63x |
| EV / FCF | - | - | - |
| FCF Yield | - | - | - |
| Dividend per Share 2 | - | - | - |
| Rate of return | - | - | - |
| EPS 2 | -0.9871 | -0.9722 | -1.175 |
| Distribution rate | - | - | - |
| Net sales 1 | 27.36 | 27.22 | 20.08 |
| EBITDA 1 | -51.31 | -159.9 | -162.5 |
| EBIT 1 | -54.64 | -167.6 | -174.5 |
| Net income 1 | -49.23 | -118.7 | -146 |
| Net Debt 1 | -557 | -491.9 | -344.1 |
| Reference price 2 | 14.593 | 4.424 | 5.032 |
| Nbr of stocks (in thousands) | 120,388 | 122,878 | 124,940 |
| Announcement Date | 3/23/22 | 3/23/23 | 3/21/24 |
1GBP in Million2GBP
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 633M | ||
| 20.87x | 7.45x | 14.96x | 1.42% | 71.53B | ||
| 31.24x | 9x | 28.05x | 0.04% | 60.12B | ||
| 34.13x | 6.11x | 18.31x | 0.95% | 48.85B | ||
| 34.64x | 3.34x | 14.41x | -.--% | 44.28B | ||
| -21.08x | 228.26x | -22.72x | -.--% | 43.83B | ||
| 47.85x | 5.53x | 30.37x | -.--% | 41.53B | ||
| 27.07x | 7.8x | 20.09x | 0.42% | 30.13B | ||
| 32.39x | 6.91x | 17.94x | -.--% | 27.98B | ||
| -70.94x | 13.62x | -69.42x | -.--% | 25.25B | ||
| Average | 15.13x | 32.00x | 5.78x | 0.32% | 39.41B | |
| Weighted average by Cap. | 19.23x | 31.83x | 9.93x | 0.42% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- EXAI Stock
- Valuation Exscientia plc
Select your edition
All financial news and data tailored to specific country editions
















